S'abonner

The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer - 12/10/16

Doi : 10.1016/j.urology.2016.06.042 
Nataniel H. Lester-Coll a, * , Henry S. Park a, Charles E. Rutter a, Christopher D. Corso a, Brandon R. Mancini a, Debra N. Yeboa a, Simon P. Kim b, Cary P. Gross c, d, e, James B. Yu a, c, d
a Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 
b Urology Institute, Case Western Reserve University School of Medicine, University Hospital Case Medical Center, Cleveland, OH 
c Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT 
d Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine, New Haven, CT 
e Department of Internal Medicine, Yale School of Medicine, New Haven, CT 

*Address correspondence to: Nataniel H. Lester-Coll, M.D., Smilow Cancer Hospital, Radiation Oncology Lower Level Box 21, 20 York Street, New Haven, CT 06511.Smilow Cancer HospitalRadiation Oncology Lower Level Box 21, 20 York StreetNew HavenCT06511

Abstract

Objective

To identify factors associated with expectant management (EM) in a large cohort of men with low-risk prostate cancer based on cancer center type (community vs academic). EM, consisting of active surveillance or observation for men with low-risk prostate cancer, is an increasingly recognized management option, given the morbidity and lack of a survival benefit associated with definitive treatment. However, the influence of cancer center type on treatment selection is uncertain.

Materials and Methods

We performed a retrospective analysis of the National Cancer Data Base from 2010 to 2013. Men with low-risk prostate cancer were divided by management strategy into groups consisting of EM or definitive treatment. The association between management strategy and facility type (community vs academic) was characterized using 2-level hierarchical mixed effects logistic regression models.

Results

There were 52,417 (57%) men evaluated at community centers and 39,139 men (43%) evaluated at academic centers. Patients evaluated at academic centers were significantly more likely to receive EM than those at community centers (17% vs 8%, P < .001). After adjusting for pertinent covariates, evaluation at an academic vs community facility was independently associated with increased odds of EM utilization (adjusted odds ratio 2.70, 95% confidence interval 2.00-3.66). Fifty-one percent of the total variance was explained by interfacility variation.

Conclusion

The likelihood of receiving EM for low-risk prostate cancer was significantly lower in men evaluated at community centers. Further investigation is warranted to elucidate factors that influence the management of low-risk prostate cancer, including individual treatment center patterns.

Le texte complet de cet article est disponible en PDF.

Plan


 Financial Disclosure: Drs. Lester-Coll, Rutter, and Corso received funding from Elekta AB, unrelated to the current work. Dr. Yu and Dr. Gross receive research funding from 21st century oncology LLC, unrelated to the current work. Dr. Gross also receives funding from Medtronic and Johnson & Johnson, unrelated to the current work. The remaining authors declare that they have no relevant financial interests.


© 2016  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 96

P. 128-135 - octobre 2016 Retour au numéro
Article précédent Article précédent
  • Racial and Ethnic Variation in Time to Prostate Biopsy After an Elevated Screening Level of Serum Prostate-specific Antigen
  • Stephanie R. Reading, Kimberly R. Porter, Jin-Wen Y. Hsu, Lauren P. Wallner, Ronald K. Loo, Steven J. Jacobsen
| Article suivant Article suivant
  • Editorial Comment
  • James E. Montie

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.